Intermed Labs at Mon Health Wins Top Innovation Award at National Plastic Surgery Conference | Newsroom

Published date: 11/3/2022

Intermed Labs at Mon Health Wins Top Innovation Award at National Plastic Surgery Conference

Dr. Tom McClellan, third from left, with judges from The Tank: Plastic Surgery Innovation Challenge.

Intermed Labs at Mon Health was awarded the Top Innovator of 2022 for its Fingy3D device during The Tank: Plastic Surgery Innovation Challenge hosted by the American Society of Plastic Surgeons (ASPS), the world’s largest organization of board-certified plastic surgeons.

During the ASPS National Meeting on Friday, October 28 in Boston, MA, thousands of plastic, reconstructive and hand surgeons from around the world met. Dr. Tom McClellan, co-founder of Intermed Labs at Mon Health, presented against three other finalists from Dartmouth, University of Pittsburgh Medical Center and Washington University, who were selected among many applications from across the country.

Also Read :  Cheetah will face hostile environment in India, difficult to survive, says Ullas Karanth

Judges on the panel included distinguished medical innovators, venture capitalists, and the former president of the ASPS. The Top Innovator Award also includes a $10,000 monetary prize to be used to further advance the project.

“Winning this national competition against such distinguished medical centers is a tremendous honor for our state, Mon Health System, our patients, and it highlights the talented people who worked tirelessly on this project,” said Dr. McClellan. “I think the judges were impressed by our quality team and the elegant solution we created for patient access to prosthetics.”

Fingy3D is a custom, functional 3D printed finger prosthetic that can be ordered upon request at The revolutionary product aims to improve access, cost and function for patients who have experienced a finger or partial hand loss.

Also Read :  Speech as a New Diagnostic Tool in ALS and FTD

The device is entering its final stages and will soon begin a pilot trial with hand surgery patients and surgeons at the University of Washington in Seattle, WA and Emory University in Atlanta, GA.

“Intermed Labs at Mon Health continues to drive the future of healthcare with the innovation of our entrepreneurs. Our world-class team builds, prototypes and grows ideas from across the country to improve patient outcomes and quality of life, right here close to home “said David Goldberg, President and CEO of Mon Health System and Executive Vice President of Vandalia Health.

Also Read :  Scientists Discover Depression Treatment Increases Brain Connectivity

“West Virginia has an abundance of bright and innovative young people who have an inexhaustible work ethic. Intermed Labs at Mon Health has created the startup environment necessary for innovators to succeed globally, as evidenced by industry leaders visiting Morgantown , use our products and evaluate our future innovations,” said Dr. McClellan. “I have no doubt that we can build a thriving medtech ecosystem in the state.”

To learn more about Fingy3D, visit To learn more about Intermed Labs, visit

Related doctors

This record has been viewed 2 sometimes


Leave a Reply

Your email address will not be published.